The global cellular starting materials marketsize was valued estimated at USD 1.16 billion in 2023 and is projected to grow at a compound annual growth rate CAGR of 22.74% from 2024 to 2030. The rising prevalence of chronic diseases such as cancer, diabetes, & autoimmune disorders, i... Read More »
July 2024The global single-use bioprocessing probes & sensors market size was estimated at USD 2.99 billion in 2023 and is projected to grow at a CAGR of 11.32% from 2024 to 2030. Increasing implementation of single-use technology (SUT) for bioproduction, commercial advantages over convention... Read More »
July 2024The global microbiology & bacterial culture for industrial testing market size was estimated to be USD 6.74 billion in 2023 and is expected to grow at a CAGR of 7.09% from 2024 to 2030. Growth of the market can be attributed to the growing developments in the microbiology industry du... Read More »
June 2024The global laboratory robotics market size was estimated at USD 2,353.3 million in 2023 and is projected to reach USD 3,864.4 million by 2030, growing at a CAGR of 7.1% from 2024 to 2030. The increasing demand for efficient & cost-effective laboratory operations, the need for automation in high-throughput t... Read More »
June 2024The global protein labeling market size was estimated at USD 2.43 billion in 2023 and is projected to grow at a CAGR of 8.46% from 2024 to 2030. Market growth can be attributed to the increase in spending on proteomics research, rapid technological advancements in the market, and the ris... Read More »
June 2024The global primary cells market size was estimated at USD 2.02 billion in 2023 and is projected to reach USD 4.00 billion by 2030, growing at a CAGR of 10.39% from 2024 to 2030. This growth can be attributed to the increasing demand for monoclonal antibodies, increasing cancer research, ... Read More »
June 2024The U.S. epigenetics market size was estimated at USD 5.13 billion in 2023 and is projected to witness a CAGR of 14.5% from 2024 to 2030. This growth can be attributed to the pivotal role of epigenetics in understanding gene regulation beyond DNA sequencing, aiding disease research, and ... Read More »
June 2024The Asia Pacific viral vector and plasmid DNA manufacturing market size was estimated at USD 1.0 billion in 2023 and is anticipated to grow at a CAGR of 21.9% from 2024 to 2030. The growth is attributed to the growing incidence of target conditions and diseases, as well as the effectiven... Read More »
June 2024The Europe viral vector and plasmid DNA manufacturing market size was estimated at USD 1.3 billion in 2023 and is anticipated to grow at a CAGR of 20.0% from 2024 to 2030. The market growth can be attributed to an increase in research funding and the presence of local key market players ... Read More »
June 2024The U.S. viral vector and plasmid DNA manufacturing market size was estimated at USD 2.2 billion in 2023 and is anticipated to grow at a CAGR of 20.0% from 2024 to 2030. This can be attributed to the growing engagement of companies in research and product development in gene & cell t... Read More »
June 2024The U.S. metagenomics market size was valued at USD 776.5 million in 2023 and is projected to grow at a CAGR of 12.99% over the forecast period of 2024 to 2030. This can be attributed to the extensive genomics, oncology, and whole-genome sequencing research. Other factors contributing to... Read More »
June 2024The U.S. glycomics market size was estimated at USD 620.08 million in 2023 and is projected to grow at a CAGR of 12.0% from 2024 to 2030. The gGrowing focus on glycomics and proteomics, rising investments in research by various government bodies, and development of novel drugs by pharmac... Read More »
June 2024The U.S. oligonucleotide synthesis market size was estimated at USD 1.36 billion in 2023 and is projected to grow at a CAGR of 12.80% from 2024 to 2030. The growth can be attributed to the increasing demand for synthetic DNA & RNA sequences in various applications, such as research, ... Read More »
May 2024The global protein engineering market size was estimated at USD 2.60 billion in 2023 and is expected to grow at a CAGR of 16.24% from 2024 to 2030. The market growth can be attributed to a number of factors, including the increased focus of biotechnology and pharmaceutical businesses on research & developme... Read More »
May 2024The global upstream bioprocessing market was estimated at USD 24.12 billion in 2023 and is projected to grow at a CAGR of 14.3% from 2024 to 2030. Market growth can be attributed to the advantages associated with the implementation of single-use technology in the bio manufacturing proces... Read More »
May 2024The U.S. genomics market size was estimated at USD 12.0 billion in 2023 and is projected to grow at a CAGR of 16.9% from 2024 to 2030. The increasing demand for gene therapy and personalized medicine has significantly boosted investment in genomics research and development. Additionally,... Read More »
May 2024The Europe genomics market size was estimated at USD 9.8 billion in 2023 and is projected to grow at a CAGR of 16.3% from 2024 to 2030. This surge can be attributed to several key factors including the advancements in genomic research and technology that have paved the way for personaliz... Read More »
May 2024The U.S. regenerative medicine market size was valued at USD 16.81 billion in 2023 and is expected to grow at a CAGR of 16.72% from 2024 to 2030. The growth can be attributed to factors such as increasing investments in the regenerative medicine domain and a growing focus on launching ne... Read More »
May 2024The U.S. scaffold technology market size was estimated at USD 674.21 million in 2023 and is expected to register a CAGR of 13.57% from 2024 to 2030, driven by increased demand for 3D cellular models, body reconstruction procedures, and advancements in nanofiber-based scaffold technologie... Read More »
May 2024The U.S. next-generation sequencing services market size was estimated at USD 2.48 billion in 2023 and is expected to grow a CAGR of 22.39% from 2024 to 2030. Next-generation sequencing (NGS) technology in the country is driven by a robust presence of pharmaceutical, biotech entities, an... Read More »
May 2024